XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings (Loss) Per Share
 9 Months Ended
Jul. 02, 2021
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE:Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedNine Months Ended
July 2, 2021June 26, 2020July 2, 2021June 26, 2020
Earnings (Loss):
Net income (loss) attributable to Aramark stockholders$32,557 $(256,440)$(126,262)$(312,939)
Shares:
Basic weighted-average shares outstanding
255,207 252,943 254,461 251,343 
Effect of dilutive securities(1)
2,167 — — — 
Diluted weighted-average shares outstanding
257,374 252,943 254,461 251,343 
Basic Earnings (Loss) Per Share:
Net income (loss) attributable to Aramark stockholders$0.13 $(1.01)$(0.50)$(1.25)
Diluted Earnings (Loss) Per Share:
Net income (loss) attributable to Aramark stockholders$0.13 $(1.01)$(0.50)$(1.25)
(1)
Incremental shares of 2.1 million have been excluded from the computation of diluted weighted-average shares outstanding for the nine months ended July 2, 2021 because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during the period. Incremental shares of 0.8 million and 2.6 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and nine months ended June 26, 2020, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods.
Share-based awards to purchase 8.5 million and 8.8 million shares were outstanding for the three months ended July 2, 2021 and June 26, 2020, respectively, but were not included in the computation of diluted earnings (loss) per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.1 million and 1.6 million shares were outstanding for the three months ended July 2, 2021 and June 26, 2020, respectively, but were not included in the computation of diluted earnings (loss) per common share, as the performance targets were not yet met.
Share-based awards to purchase 9.4 million and 5.3 million shares were outstanding for the nine months ended July 2, 2021 and June 26, 2020, respectively, but were not included in the computation of diluted loss per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.1 million and 1.6 million shares were outstanding for the nine months ended July 2, 2021 and June 26, 2020, respectively, but were not included in the computation of diluted loss per common share, as the performance targets were not yet met.